Cargando…
Altered beta-tubulin isotype expression in paclitaxel-resistant human prostate carcinoma cells.
To investigate the role of beta-tubulin isotype composition in resistance to paclitaxel, an anti-microtubule agent, human prostate carcinoma (DU-145) cells were intermittently exposed to increasing concentrations of paclitaxel. Cells that were selected and maintained at 10 nM paclitaxel (Pac-10) wer...
Autores principales: | Ranganathan, S., Benetatos, C. A., Colarusso, P. J., Dexter, D. W., Hudes, G. R. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2149944/ https://www.ncbi.nlm.nih.gov/pubmed/9484812 |
Ejemplares similares
-
Modulation of endogenous β-tubulin isotype expression as a result of human β(III) cDNA transfection into prostate carcinoma cells
por: Ranganathan, S, et al.
Publicado: (2001) -
Cancer Cells Acquire Mitotic Drug Resistance Properties Through Beta I-Tubulin Mutations and Alterations in the Expression of Beta-Tubulin Isotypes
por: Cheung, Chun Hei Antonio, et al.
Publicado: (2010) -
The mammalian beta-tubulin repertoire: hematopoietic expression of a novel, heterologous beta-tubulin isotype
Publicado: (1986) -
Differential utilization of beta-tubulin isotypes in differentiating neurites
Publicado: (1989) -
Rationalization of paclitaxel insensitivity of yeast β-tubulin and human βIII-tubulin isotype using principal component analysis
por: Das, Lalita, et al.
Publicado: (2012)